Propionibacterium acnes and Staphylococcus epidermidis are normal skin inhabitants that are frequently isolated from lesions caused by acne, and these micro-organisms are considered to contribute to the inflammation of acne. In the present study, we examined the antimicrobial susceptibilities and resistance mechanisms of P. acnes and S. epidermidis isolated from patients with acne vulgaris in a university hospital in Japan from 2009 to 2010. Additionally, we analysed the relationship between the antimicrobial resistance of P. acnes and the severity of acne vulgaris. Some P. acnes strains (18.8 %; 13/69) were resistant to clindamycin. All strains had a mutation in the 23S rRNA gene, except for one strain that expressed erm(X) encoding a 23S rRNA methylase. Tetracycline-resistant P. acnes strains were found to represent 4.3 % (3/69) of the strains, and this resistance was caused by a mutation in the 16S rRNA gene. Furthermore, three strains with reduced susceptibility to nadifloxacin (MIC516 mg ml "1 ) were detected. When analysing the correlation between the antimicrobial resistance of P. acnes and S. epidermidis, more than 80 % of the patients who carried clindamycin-resistant P. acnes also carried clindamycin-resistant S. epidermidis. However, no epidemic strain that exhibited antimicrobial resistance was detected in the P. acnes strains when analysed by PFGE. Therefore, our results suggest that the antimicrobial resistance of P. acnes is closely related to antimicrobial therapy. Additionally, those P. acnes strains tended to be frequently found in severe acne patients rather than in mild acne patients. Consequently, the data support a relationship between using antimicrobial agents and the emergence of antimicrobial resistance.
INTRODUCTION
Propionibacterium acnes and Staphylococcus epidermidis, which are normal inhabitants of the skin, were isolated from acne vulgaris inflammatory sites of patients (Kim et al., 2008; Nishijima et al., 2000) . P. acnes is regarded as a cause of the pathogenesis and exacerbation of acne vulgaris, and antimicrobial therapy for P. acnes is provided for acne vulgaris cases (Iinuma et al., 2009) . Recently, global reports have shown that the antimicrobial susceptibility varies for P. acnes isolated from patients with acne vulgaris. In Europe and the United States, antimicrobialresistant P. acnes strains have been isolated frequently and have become a large problem (Leyden, 2004; Ross et al., 2003; Thiboutot et al., 2009) . A previous study that investigated the antimicrobial susceptibilities of P. acnes and S. epidermidis isolated from acne patients in a university hospital in Japan from 1996 to 1997 revealed few resistant strains of P. acnes, and that S. epidermidis showed a high susceptibility to antimicrobials (Nishijima et al., 2000) . In addition to the classical oral minocycline doxycycline, which has been approved for the treatment of acne, the oral macrolides roxithromycin and clarithromycin, topical nadifloxacin and topical clindamycin were approved in 1991, 1993 and 2002, respectively, in Japan. These oral and topical antimicrobial agents for acne therapy are commonly used, and the number of clindamycin-resistant strains is increasing (Nakase et al., 2012) . Lincosamideresistant strains are known as macrolide-lincosamidestreptogramin B (MLS B )-resistant and show cross-resistance IP: 54.70.40.11
On: Sat, 30 Mar 2019 20:11:42 to macrolides and streptogramin B by binding to an identical region of the 23S rRNA (Ross et al., 2002) . Two mechanisms of resistance of MLS B in P. acnes are known. One mechanism involves an rRNA methylase, which is encoded by erm(X), that modifies the 23S rRNA of the 50S subunit and contributes to the high-level of MLS B resistance. The other mechanism involves mutations in the peptidyltransferase region of the 23S rRNA, which results in different MLS B resistance characteristics according to the point mutation (Ross et al., 2003) . Fluoroquinolone-resistant P. acnes has not been reported, but cases of tetracyclineresistant P. acnes caused by mutation of the 16S rRNA have been reported (Oprica et al., 2005; Ross et al., 2002) .
Although S. epidermidis functions on the skin barrier, multi-drug-resistant strains carry multiple resistance determinants, e.g. meticillin-resistant S. epidermidis (MRSE), which has an acquired meticillin resistance gene (mecA) (Hisata et al., 2005; Otto, 2009 ). S. epidermidis causes an opportunistic infection and has the potential to become a reservoir of antimicrobial resistance genes (Bisno, 1984) . A previous study investigated the antimicrobial susceptibilities of P. acnes and S. epidermidis isolated from patients with acne vulgaris in a university hospital in Japan from 1996 to 1997 (Nishijima et al., 2000) . At that time, no antimicrobial-resistant strains were found for P. acnes, and S. epidermidis showed a high susceptibility to antimicrobials. In the present study, we examined the antimicrobial susceptibilities and resistance mechanisms of P. acnes and S. epidermidis isolated from patients with acne vulgaris in a university hospital in Japan from 2009 to 2010.
METHODS
Bacterial strains and growth conditions. Sixty-nine P. acnes and 58 S. epidermidis strains were collected from 91 patients (ratio of males to females, 18 : 73; mean age, 25.5 years) with acne vulgaris at the Tokyo Women's Medical University in Japan from 2009 to 2010. P. acnes ATCC 11828, S. epidermidis ATCC 14990, Staphylococcus aureus ATCC 29213 and S. aureus N315 were used as quality control strains for antimicrobial susceptibility testing. P. acnes ATCC 11828 was used as a wild-type strain for 23S rRNA and 16S rRNA (GenBank accession no. CP003084). The samples were spread onto mannitol salt agar (MSA: Oxoid) and modified GAM agar (GAM; Nissui Pharmaceutical). The MSA was then incubated under aerobic conditions at 35 uC for 24 h, and the GAM was incubated under anaerobic conditions at 35 uC for 72 h. The bacterial strains that grew on MSA and GAM were identified using API Staph (bioMérieux) and API 20A (bioMérieux), respectively. Typing of P. acnes was performed using the method described by Shannon et al. (2006) . Susceptibility testing. The antimicrobial susceptibility of P. acnes strains was determined by a dilution procedure using brucella agar (Becton Dickinson) containing 5 % (v/v) lysed defibrinated sheep's blood (Nippon Bio-Test Laboratories) (CLSI, 2011 (CLSI, , 2012 . The MIC was determined after incubation under anaerobic conditions at 35 uC for 48 h. The antimicrobial susceptibility of S. epidermidis strains was determined using the agar dilution procedure with Mueller-Hinton agar (Oxoid) (CLSI, 2009). The MIC was determined after incubation under aerobic conditions at 35 uC for 24 h. Cefditoren sodium, faropenem sodium and nadifloxacin were kindly provided by their manufacturers. Amoxicillin, oxacillin sodium, cefaclor, cefdinir, levofloxacin hydrochloride, erythromycin, clarithromycin, roxithromycin, clindamycin hydrochloride, doxycycline hyclate, minocycline hydrochloride and fusidic acid sodium were purchased from Sigma-Aldrich. Ciprofloxacin hydrochloride, gentamicin sulphate and chloramphenicol were purchased from Wako Pure Chemical Industries. The breakpoints for the antimicrobial agents were defined using the MIC values for the quality control strains and the CLSI criteria (CLSI, 2011 (CLSI, , 2012 Nakaminami et al., 2008; Nakase et al., 2012) .
Determination of antimicrobial resistance mechanisms in P.
acnes. The detection of erm(X) using PCR was performed as previously described (Ishida et al., 2008; Nakase et al., 2012) , and the sequences of the amplified erm(X) genes were verified by DNA sequencing. The presence of a 23S rRNA mutation was determined using DNA sequencing as previously described (Nakase et al., 2012) . The presence of a mutation in the 16S rRNA gene that causes tetracycline resistance was also determined using DNA sequencing. The primers 8UA (59-AGAGTTTGATCMTGGCTCAG-39) and 1485B (59-TACGGTTACCTTGTTACGAC-39) were used to amplify the 16S rRNA gene (Noguchi et al., 2011) . The primers acnes 16S_seq-F (59-GAGCGAACAGGCTTAGATAC-39) and acnes 16S_seq-R (59-TCG-GGTGTTACCAACTTTCA-39) were designed and used as sequencing primers.
Detection of antimicrobial resistance genes in S. epidermidis.
The detection of antimicrobial resistance genes [mecA, ermA, ermB, ermC, msrA/B, mphC, tetK, tetM, aac(69)-aph(29), aph(39), aad(49,40) and ant(49)] in S. epidermidis was performed as previously described (de Vries et al., 2009; Gó mez-Sanz et al., 2011; Lina et al., 1999; Nakaminami et al., 2008) . SCCmec typing was performed according to the method of Boye et al. (2007) .
PFGE analysis for P. acnes. PFGE analysis of P. acnes was performed using a modification of the method described by Oprica et al. (2004) that utilized the SpeI restriction enzyme. The samples were lysed using 12.5 g lysozyme l 21 (Wako) for 6 h and loaded onto a 1 % (w/v) pulsed-field-certified agarose gel (Bio-Rad) with the following running conditions: initial switch time, 2.16 s; final switch time, 8.53 s; run time, 24 h; angle, 120u; gradient, 6.0 V cm 21 ; temperature, 14 uC; and ramping factor, linear. The resulting PFGE patterns were analysed using Bio Numerics version 6.01 (Applied Maths), and dendrograms were created using the unweighted pair group method of averages (UPGMA) calculated according to the method of Dice (band tolerance, 1.5 %; optimization, 1.5 %) (Noguchi et al., 2011) .
Statistical analysis. Differences in the severity grade of acne vulgaris and patient age were compared using Student's t-test. A chi-squared test was used to compare the severity grade of acne vulgaris and the percentages of MLS B resistance. The odds ratios for these data were calculated using the statistical analysis software JMP (SAS Institute) with a 95 % confidence interval.
RESULTS

Patient histories
Of the 91 patients, 18 were male (14-35 years; mean age, 22.4 years), and 73 were female (18-47 years; mean age, 26.2 years).
The severity of acne vulgaris in patients was determined according to the Japanese Dermatological Association acne vulgaris treatment guideline, and two (2.2 %) and 14 patients (15.4 %) were classified as having very severe and severe acne vulgaris, respectively ( Fig. 1a ) (Hayashi et al., 2008) . A comparative analysis showed that the mean age of the patients with severe acne vulgaris (23.3 years) was significantly lower than that of the patients with mild acne vulgaris (26.9 years, P50.042) (Fig. 1b ). The duration of acne vulgaris ranged from three days to 22 years. P. acnes and S. epidermidis were isolated from 69 patients (75.8 %) and 58 patients (63.7 %), respectively. Within a year, 59 of the patients (64.8 %) were treated with antimicrobial agents. Clindamycin, fluoroquinolones, tetracyclines and macrolides were used on 39 (66.1 %), 22 (37.3 %), 18 (30.5 %) and 15 (25.4 %) of the patients, respectively.
Antimicrobial susceptibility
Antimicrobial susceptibility testing was performed on 69 P. acnes and 58 S. epidermidis isolates that were collected from 91 patients with acne vulgaris (Table 1 ). All P. acnes strains were susceptible to b-lactams, and reduced susceptibilities (MIC516 mg ml 21 ) to nadifloxacin (fluoroquinolone) and doxycycline (tetracycline) were found in three strains (4.3 %). The MIC 90 of the macrolides and clindamycin was ¢64 mg ml 21 , and 16 strains (23.2 %) were resistant to those agents.
In S. epidermidis, b-lactams, macrolides, clindamycin and gentamicin showed high MIC 90 values, and strains were found that were resistant to all of the antimicrobial agents. Especially, oxacillin-, levofloxacin-, gentamicinand MLS B -resistant strains were found in 16 (27.6 %), 21 (36.2 %), 11 (19.0 %) and 34 (58.6 %) strains, respectively.
Analysis of antimicrobial resistance mechanisms
We determined the MLS B resistance mechanisms using 23S rRNA gene sequencing and the detection of erm(X) for 16 MLS B -resistant P. acnes strains (Table 2) . Furthermore, we determined the tetracycline resistance mechanism using 16S rRNA gene sequencing. The erm(X) gene was detected in one strain, and this strain showed high-level MLS B resistance. The A2058G mutation in the 23S rRNA was detected in 11 strains (68.8 %), and this mutation was predominant in MLS B -resistant P. acnes. Despite resistance to clarithromycin, no MLS B resistance determinant was detected in strain 68b. The G1058C mutation in the 16S rRNA was detected in three strains that had reduced doxycycline susceptibility.
In S. epidermidis, various antimicrobial resistance genes were detected (Table 3 ). When SCCmec typing was performed in 19 strains that carried mecA, types I, IV and V were detected in seven (36.8 %), 10 (52.6 %) and two (10.5 %) of the strains, respectively (Table 4 ). At least one of the MLS B resistance genes was found in 35 strains (60.3 %). The tetracycline resistance genes tetK and tetM were detected in nine (15.5 %) and four (6.9 %) strains, respectively. The aminoglycosides resistance gene aac(69)aph(29) (aacA-aphD) was detected in 15 strains (25.9 %).
PFGE analysis for P. acnes
To analyse the relatedness of the strains, the molecular epidemiological characteristics of P. acnes isolated from patients with acne vulgaris were determined using PFGE analysis (Fig. 2) . Additionally, the susceptibility of the strains to MLS B and the severity grade of acne vulgaris in the patients were compared. We did not obtain a clear PFGE result for one of the strains; thus, the data were omitted from the present study.
Several strains showed identical PFGE patterns. However, no common background was observed among patients carrying P. acnes with identical PFGE patterns. The strains were classified into two groups (A and B) according to the DResistance breakpoints of nadifloxacin and gentamicin were not established in P. acnes. Resistance breakpoints of the following antimicrobial agents were defined according to a previous study: spiramycin, ¢8 mg ml 21 ; minocycline, ¢16 mg ml 21 ; fusidic acid, ¢32 mg ml 21 for P. acnes. dSusceptibility to oxacillin was not measured in P. acnes. PFGE pattern. Type IA and IB strains were classified into group A, and type II strains were classified into group B. Whereas all strains with the A2058G mutation in the 23S rRNA were placed in PFGE group A, all strains with the A2059G mutation in the 23S rRNA were placed in PFGE group B. Furthermore, the number of strains in PFGE group A (13 strains) that were isolated from patients with severe acne vulgaris was greater than that in PFGE group B (one strain). The severity of acne vulgaris and isolation rate of MLS B -resistant strains was compared (Fig. 1b) . The isolation rates of the MLS B -resistant strains were 40.0 % (6/15), 12.9 % (4/31) and 18.8 % (3/16) in the patients with severe, moderate and mild acne vulgaris, respectively.
DISCUSSION
P. acnes and S. epidermidis have been primarily isolated from acne vulgaris patients; however, we found few reports discussing sampling of those bacteria from acne patients. The pathogenesis of acne vulgaris is also affected by the balance of hormones, which tends to be worse during adolescence when the secretion of hormones increases. Thus, pathogenesis involves bacterial and host biological effects (Dipiro et al., 2005) .
Because the subjects of the study were outpatients with acne vulgaris who were in the university hospital, this study had a large number of intractable cases of patients who had already been treated with an antimicrobial agent. The isolation rate of MLS B -resistant P. acnes in severe acne patients (40.0 %) was higher than that of mild acne patients (18.8 %), although no significant difference was found (P50.193). No significant difference was found between the ages of patients (25.4, n516) carrying MLS B -resistant P. acnes and those (24.7, n553) carrying susceptible P. acnes (P50.34). The mean age of the severe acne patients was significantly lower than that of mild acne patients in the present study. These data were different from those of a previous report (Schafer et al., 2013) ; Japanese acne patients who feel the stress of acne vulgaris are believed to usually visit a doctor in their adolescent years. In the present study, no significant differences were found between severity grades and treatment histories of acne vulgaris or between treatment history with macrolides and the isolation rate of MLS B -resistant P. acnes.
Reduced antimicrobial susceptibility of P. acnes isolated from patients with acne vulgaris has been found throughout the world (El-Mahdy et al., 2010; Mendoza et al., 2013) . Nishijima et al. (2000) found 30.8 % MLS B -resistant S. epidermidis strains but no P. acnes strains. In the present study, MLS B -resistant strains were 23.2 % and 58.6 % P. acnes and S. epidermidis, respectively. Therefore, our data showed that the rate of acquiring antimicrobial resistance has increased in bacteria isolated from acne lesions.
In Japan, P. acnes that carries erm(X), which is involved in high-level MLS B resistance, was first detected in 2008 (Nakase et al., 2012) . The 23S dimethylase encoded by erm(X) causes dimethylation of the peptidyltransferase region of domain V of the 23S rRNA, which decreases drug affinity. The prevalence of the erm(X) gene causes serious clinical concerns because P. acnes strains that carry erm(X) exhibit high-level resistance to oral macrolides and topical clindamycin. The transposon Tn5432, which contains erm(X), was first found in Corynebacterium; and the only other bacterial species that Tn5432 has been found in is P. acnes (Ross et al., 2002) . Although erm(X) was detected in three strains, two of the strains were omitted from the present study because the strains were identified as Propionibacterium granulosum and Propionibacterium avidum by 16S rRNA gene sequencing (data not shown). Although P. acnes strains that carry erm(X) have been reported elsewhere, the percentage of those strains among all MLS B -resistant strains was low. The percentage of P. acnes strains that carry erm(X) may be further decreased by the accurate identification of bacterial species using DNA sequencing. We presumed that although erm(X) results in high-level MLS B resistance, this resistance determinant may be difficult to maintain on the chromosome of P. acnes.
Our data showed that most MLS B -resistant P. acnes strains had a 23S rRNA mutation, and the A2058G mutation was the most frequent for MLS B resistance. Additionally, we found one MLS B -resistant strain without the resistance determinant. Further investigation is necessary to understand the unknown mechanism of MLS B resistance.
Nadifloxacin is widely used in the world. However, no nadifloxacin-resistant strains have been found in P. acnes, and strains with reduced susceptibility (MIC516 mg ml 21 ) were first found in this study. Topical drugs can administer a high concentration of the antimicrobial onto skin surfaces because the drugs are directly applied. If topical nadifloxacin (1 %) is applied by one finger-tip unit to the skin at 5 cm 2 , the amount of nadifloxacin is expected to be approximately 600 mg cm 22 (Long et al., 1998) . While topical clindamycin is also expected to achieve similar concentrations, it is possible that an insufficient therapeutic effect will be obtained in the presence of high-level clindamycin-resistant P. acnes strains that carry erm(X). Therefore, topical nadifloxacin is considered to have a sufficient bactericidal effect against P. acnes with reduced fluoroquinolone susceptibility. Mutations in DNA gyrase and/or DNA topoisomerase are known to be major mechanisms of fluoroquinolone resistance; however, those mechanisms have not been observed in P. acnes. Further analysis is necessary to discover the fluoroquinolone resistance factors in P. acnes.
Resistance to tetracyclines is caused by increasing the activity of an efflux pump, ribosomal protection and mutation of drug binding points (Ross et al., 2003) . The present study found the first strains with the G1058C mutation of the 16S rRNA gene in P. acnes in Japan. When the histories of acne treatments were verified, 77.8 % (7/9) of the patients carrying P. acnes with reduced tetracycline susceptibility and 81.3 % (13/16) of the patients carrying MLS B -resistant P. acnes had used the respective antimicrobial agents (data not shown). Additionally, more than 80 % of the patients who carried MLS B -resistant P. acnes also carried MLS B -resistant S. epidermidis (data not shown). Our data strongly suggest that the 16S rRNA mutation for tetracycline resistance and the 23S rRNA mutation for macrolide resistance in P. acnes were caused by the use of antimicrobial agents. Therefore, minocycline is considered to have a more effective therapeutic effect than oral macrolides for acne vulgaris because no P. acnes strains were resistant to this drug in this study or in previous reports.
PFGE analysis suggested that the mutation points of the 23S rRNA in P. acnes were different according to the genetic background. Furthermore, nearly all strains that were isolated from patients with severe acne vulgaris belonged to the same PFGE group. Additionally, a clear relationship was found between the severity grade of acne vulgaris and the MLS B resistance rate of P. acnes. Our data showed that the antimicrobial resistance of P. acnes was closely related to the severity of acne vulgaris.
Understanding the trend of antimicrobial susceptibilities of S. epidermidis isolated from patients with acne vulgaris is valuable because few studies have been reported. In addition to Staphylococcus aureus, S. epidermidis is one of the normal inhabitants of the skin and easily acquires and transmits the various antimicrobial resistance genes (Bloemendaal et al., 2010) . In our study, SCCmec type II, which is primarily detected in hospital-acquired strains, was not found in S. epidermidis strains carrying mecA. MLS B -and aminoglycoside-resistance genes were detected in 60.2 % and 29.2 % of strains, respectively. The prevalence of those antimicrobial resistance genes in S. epidermidis may be caused by the use of clindamycin and gentamicin in treating skin and soft tissue staphylococci infections. Although the pathogenicity of S. epidermidis for acne vulgaris remains unclear, S. epidermidis could become a reservoir of various antimicrobial resistance genes on the skin.
In conclusion, the existence of antimicrobial-resistant bacteria should be considered when selecting antimicrobial therapy for inflammatory acne, and antimicrobials should not be used for the maintenance therapy of acne vulgaris. Additionally, following an approval of adapalene, benzoyl peroxide, which is an alternative antimicrobial agent, may have an important role in the prevention of antimicrobialresistant P. acnes.
